Perrigo | PRGO - Actif À Court Terme





Actif À Court Terme Changement Date
AbbVie USD 37.48B 3.81B 2026-09
Abbott USD 23.5B 1.02B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Corcept Therapeutics USD 533.87M 94.2M 2026-09
Dr.Reddys Laboratories INR 297.32B 2.01B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
J&J USD 56.35B 3.42B 2026-09
Merck USD 38.94B 2.26B 2026-09
Nestle CHF 37.58B 5.61B 2026-06
Pacira USD 10.3B 9.68B 2026-09
Perrigo USD 2.4B 49.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Phibro Animal Health USD 945.17M 9.67M 2026-09
Prestige Brands USD 492.13M 4.69M 2026-09
Reckitt Benckiser GBP 4.6B 287M 2024-12
Sanofi EUR 33.21B 1.68B 2026-09
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09
Xeris Pharmaceuticals USD 289.26M 14.51M 2026-09
Zoetis USD 6.29B 63M 2026-09